Canada markets closed

CSPC Pharmaceutical Group Limited (CVG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.0450+0.0025 (+0.24%)
At close: 08:04AM CET
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
Total Revenue
29,654,621
27,866,870
24,942,204
22,103,192
Cost of Revenue
7,705,708
6,731,776
6,256,882
6,192,211
Gross Profit
21,948,913
21,135,094
18,685,322
15,910,981
Operating Expenses
Research Development
3,703,703
3,432,590
2,889,837
2,000,426
Selling General and Administrative
11,611,051
11,453,246
10,323,333
9,460,592
Total Operating Expenses
15,067,441
14,340,142
12,628,654
11,310,800
Operating Income or Loss
6,881,472
6,794,952
6,056,668
4,600,181
Interest Expense
12,602
7,664
12,232
32,426
Income Before Tax
6,903,678
6,847,096
6,391,023
4,626,162
Income Tax Expense
1,297,582
1,158,972
1,162,013
892,810
Income from Continuing Operations
5,606,096
5,688,124
5,229,010
3,733,352
Net Income
5,508,821
5,605,185
5,159,655
3,714,106
Net Income available to common shareholders
5,508,821
5,605,185
5,159,655
3,714,106
Basic EPS
-
0.47
0.43
0.31
Diluted EPS
-
0.47
0.43
0.31
Basic Average Shares
-
11,953,486
11,954,570
11,954,966
Diluted Average Shares
-
11,953,839
11,955,537
11,956,727
EBITDA
-
7,720,231
7,212,062
5,350,183